UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 291

Sortiert nach

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR

The New England journal of medicine, 2015-07, Vol.373 (3), p.220-231

2015

Link zum Volltext

Verfügbarkeit prüfen

Recommendations for the classification of diseases as CFTR-related disorders

Journal of cystic fibrosis, 2011-06, Vol.10, p.S86-S102

2011

Link zum Volltext

Verfügbarkeit prüfen

Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice

Journal of cystic fibrosis, 2008-05, Vol.7 (3), p.179-196

2008

Link zum Volltext

Verfügbarkeit prüfen

Medical consensus, guidelines, and position papers: A policy for the ECFS

Journal of cystic fibrosis, 2014-09, Vol.13 (5), p.495-498

2014

Link zum Volltext

Verfügbarkeit prüfen

Cystic Fibrosis Foundation and European Cystic Fibrosis Society Survey of cystic fibrosis mental health care delivery

Journal of cystic fibrosis, 2015-07, Vol.14 (4), p.533-539

2015

Link zum Volltext

Verfügbarkeit prüfen

Proposed definitions of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA)

The Journal of hospital infection, 2007-10, Vol.67 (2), p.109-113

2007

Link zum Volltext

Verfügbarkeit prüfen

WS01.5 A Phase 2 study of the safety, pharmacokinetics, and efficacy of anabasum (JBT-101) in cystic fibrosis (CF)

Journal of cystic fibrosis, 2017-06, Vol.16, p.S2-S2

2017

Link zum Volltext

Verfügbarkeit prüfen

133 Multiple breath washout (MBW) testing: experiences from a training programme

Journal of cystic fibrosis, 2016-06, Vol.15, p.S84-S85

2016

Link zum Volltext

Verfügbarkeit prüfen

37 Trypsin-like protease activity predicts disease severity and patient mortality in adults with cystic fibrosis

Journal of cystic fibrosis, 2017-06, Vol.16, p.S73-S73

2017

Link zum Volltext

Verfügbarkeit prüfen

45 Development of a novel ProteaseTag™ immunoassay for the detection and measurement of cathepsin G in adult cystic fibrosis patients

Journal of cystic fibrosis, 2016-06, Vol.15, p.S63-S63

2016

Link zum Volltext

Verfügbarkeit prüfen

85 Development of an in vitro molecular diagnostic assay for CF microbiology

Journal of cystic fibrosis, 2016-06, Vol.15, p.S72-S73

2016

Link zum Volltext

Verfügbarkeit prüfen

315 Late diagnosis of CF in a family with R117H

Journal of cystic fibrosis, 2015-06, Vol.14, p.S139-S139

2015

Link zum Volltext

Verfügbarkeit prüfen

EPS7.7 Microbiologic changes in CF patients with chronic P. aeruginosa airway infection after 6 cycles of inhaled levofloxacin

Journal of cystic fibrosis, 2017-06, Vol.16, p.S54-S54

2017

Link zum Volltext

Verfügbarkeit prüfen

149 Comparison of culture and quantitative PCR for bacterial quantification in CF sputum

Journal of cystic fibrosis, 2017-06, Vol.16, p.S104-S104

2017

Link zum Volltext

Verfügbarkeit prüfen

193 In vitro synergistic effect of NaCl and antibiotics against P. aeruginosa from cystic fibrosis patients

Journal of cystic fibrosis, 2017-06, Vol.16, p.S116-S116

2017

Link zum Volltext

Verfügbarkeit prüfen

21 Lung function and disease severity in CF patients heterozygous for p. Arg117His

Journal of cystic fibrosis, 2017-06, Vol.16, p.S68-S68

2017

Link zum Volltext

Verfügbarkeit prüfen

WS03.1 Longitudinal airway microbiota profiling in cystic fibrosis patients enrolled in the CFMATTERS clinical trial

Journal of cystic fibrosis, 2017-06, Vol.16, p.S4-S4

2017

Link zum Volltext

Verfügbarkeit prüfen

194 Effect of multiple doses of ALX-009, a novel combination of hypothiocyanite and lactoferrin, on microbial load in cystic fibrosis (CF) sputum

Journal of cystic fibrosis, 2017-06, Vol.16, p.S116-S117

2017

Link zum Volltext

Verfügbarkeit prüfen

124 Lack of antimicrobial activity of ivacaftor against clinical CF respiratory isolates

Journal of cystic fibrosis, 2015-06, Vol.14, p.S88-S88

2015

Link zum Volltext

Verfügbarkeit prüfen

117 Safety profile of levofloxacin inhalation solution from 3 controlled cystic fibrosis clinical trials

Journal of cystic fibrosis, 2015-06, Vol.14, p.S87-S87

2015

Link zum Volltext

Verfügbarkeit prüfen

54 Cigarettes, e-cigarettes and Pseudomonas aeruginosa: interactions in the CF lung?

Journal of cystic fibrosis, 2016-06, Vol.15, p.S65-S65

2016

Link zum Volltext

Verfügbarkeit prüfen

140 An evaluation of cystic fibrosis (CF)-related complications and treatment in patients (pts) with CF and at least one copy of the R117H (c.350G>A) mutation in the UK and the US

Journal of cystic fibrosis, 2016-06, Vol.15, p.S86-S87

2016

Link zum Volltext

Verfügbarkeit prüfen

ePS06.6 Antimicrobial activity of a novel liposomal azithromycin formulation against clinical CF respiratory isolates

Journal of cystic fibrosis, 2016-06, Vol.15, p.S49-S49

2016

Link zum Volltext

Verfügbarkeit prüfen

WS01.4 Antimicrobial activity of innate antimicrobial peptides against clinical cystic fibrosis respiratory isolates

Journal of cystic fibrosis, 2016-06, Vol.15, p.S2-S2

2016

Link zum Volltext

Verfügbarkeit prüfen

139 Disease burden in patients (pts) with cystic fibrosis (CF) with at least one copy of the R117H (c.350G>A) mutation in the UK

Journal of cystic fibrosis, 2016-06, Vol.15, p.S86-S86

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 291

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(290)
Mit Volltextzugriff
(289)

Publikationsform

Artikel
(290)
Dissertationen
(1)

Sprache

Englisch
(291)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Pulmonary/respiratory
(172)
Humans
(64)
Life Sciences & Biomedicine
(63)
Science & Technology
(63)
Cystic Fibrosis
(39)
Adult
(31)
Biological And Medical Sciences
(27)
Female
(26)
Respiratory System
(26)
Male
(24)
Medical Sciences
(23)
Cystic Fibrosis - Microbiology
(22)
Medical Laboratory Technology
(15)
Pseudomonas Aeruginosa
(15)
Adolescent
(14)
Cystic Fibrosis - Complications
(12)
Microbiology
(12)
Sputum - Microbiology
(12)
Infectious Diseases
(11)
Pseudomonas Aeruginosa - Isolation & Purification
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR

Recommendations for the classification of diseases as CFTR-related disorders

Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice

Medical consensus, guidelines, and position papers: A policy for the ECFS

Cystic Fibrosis Foundation and European Cystic Fibrosis Society Survey of cystic fibrosis mental health care delivery

Proposed definitions of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA)

WS01.5 A Phase 2 study of the safety, pharmacokinetics, and efficacy of anabasum (JBT-101) in cystic fibrosis (CF)

133 Multiple breath washout (MBW) testing: experiences from a training programme

37 Trypsin-like protease activity predicts disease severity and patient mortality in adults with cystic fibrosis

45 Development of a novel ProteaseTag™ immunoassay for the detection and measurement of cathepsin G in adult cystic fibrosis patients

85 Development of an in vitro molecular diagnostic assay for CF microbiology

315 Late diagnosis of CF in a family with R117H

EPS7.7 Microbiologic changes in CF patients with chronic P. aeruginosa airway infection after 6 cycles of inhaled levofloxacin

149 Comparison of culture and quantitative PCR for bacterial quantification in CF sputum

193 In vitro synergistic effect of NaCl and antibiotics against P. aeruginosa from cystic fibrosis patients

21 Lung function and disease severity in CF patients heterozygous for p. Arg117His

WS03.1 Longitudinal airway microbiota profiling in cystic fibrosis patients enrolled in the CFMATTERS clinical trial

194 Effect of multiple doses of ALX-009, a novel combination of hypothiocyanite and lactoferrin, on microbial load in cystic fibrosis (CF) sputum

124 Lack of antimicrobial activity of ivacaftor against clinical CF respiratory isolates

117 Safety profile of levofloxacin inhalation solution from 3 controlled cystic fibrosis clinical trials

54 Cigarettes, e-cigarettes and Pseudomonas aeruginosa: interactions in the CF lung?

140 An evaluation of cystic fibrosis (CF)-related complications and treatment in patients (pts) with CF and at least one copy of the R117H (c.350G>A) mutation in the UK and the US

ePS06.6 Antimicrobial activity of a novel liposomal azithromycin formulation against clinical CF respiratory isolates

WS01.4 Antimicrobial activity of innate antimicrobial peptides against clinical cystic fibrosis respiratory isolates

139 Disease burden in patients (pts) with cystic fibrosis (CF) with at least one copy of the R117H (c.350G>A) mutation in the UK

Suchergebnisse filtern